The impact of the docent clinical pharmacist on treatment of streptococcal pneumonia.
This two-phase retrospective study was designed to evaluate the impact of the clinical pharmacist on prescribing practice of physicians in an internal medicine service. Streptococcal (pneumococcal) pneumonia was chosen as the model disease state. The drug of choice was used more frequently and there was a statistically significant difference in raw cost of antibiotic, total cost for antibiotic administration, daily raw cost for antibiotics; total raw cost for antibiotic administration, and patient charges when physicians were exposed to the clinical pharmacists' influence.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D006801:Humans; D008923:Missouri; D010348:Patient Care Team; D010601:Pharmacology, Clinical; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy*
D000900:Anti-Bacterial Agents